Dublin, Ireland

Stefan Oscarson

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Oscarson. Retrieved from https://idiyas.com/inventor/stefan-oscarson-puu3ilnt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stefan Oscarson: Innovator in Coronavirus Treatment

Introduction

Stefan Oscarson is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of medical research, particularly in the treatment of viral infections. His innovative work has garnered attention for its potential impact on public health.

Latest Patents

Stefan holds a patent titled "Thiosaccharides for Use in Treating Coronavirus Infection." This patent represents a crucial step in the ongoing battle against coronavirus, showcasing his commitment to developing effective treatments.

Career Highlights

Stefan is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this capacity has allowed him to contribute to important health initiatives and research projects.

Collaborations

Stefan has collaborated with esteemed colleagues, including John Vincent Fahy and Irina Gitlin. These partnerships have enhanced the scope and impact of his research efforts.

Conclusion

Stefan Oscarson's innovative contributions to the treatment of coronavirus highlight his dedication to advancing medical science. His work continues to inspire and pave the way for future breakthroughs in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…